Literature DB >> 22280546

The direct effect of hyperosmolar agents on ciliary beating of human bronchial epithelial cells.

Asma Yaghi1, Aisha Zaman, Myrna B Dolovich.   

Abstract

BACKGROUND: Inhalation of hypertonic saline and mannitol improve mucociliary clearance in patients with bronchiectasis, but little is known about how the relative osmotic strengths of these compounds affect ciliary beat frequency (CBF) of ciliated human bronchial epithelial cells (HBEC). Our aim was to compare in vitro the direct effects of osmotically equivalent solutions on CBF of HBEC.
METHODS: HBEC were acutely (10, 30 min) exposed to comparable osmolar solutions of saline (0.03-0.48%), mannitol (0.19-3%) and dextran (10%-39.39%). Effects of higher % solutions, reversibility of responses, and prolonged treatments (15-20 h) were also compared. CBF was measured using digital videomicroscopy at baseline and at all time points.
RESULTS: CBF of HBEC increased significantly after acute exposure to mannitol (0.19%, 0.38%), decreased with dextran and remained unchanged with saline. Prolonged exposure to mannitol at high (3%, 6%) osmolar concentrations reversibly suppressed CBF. In comparison, acute and prolonged treatment with 39.39% dextran (equivalent to 3% mannitol) reduced CBF irreversibly. Furthermore, acute and prolonged treatment with 1% saline (equivalent to 6% mannitol) suppressed CBF with only the acute effect being reversible.
CONCLUSIONS: Mannitol had a direct osmolarity-independent cilio-stimulatory effect at lower % solutions and a reversible cilio-inhibitory effect at higher % solutions, and prolonged exposure to mannitol inhibited CBF reversibly. Both the acute and prolonged effects of mannitol compared to dextran and saline on CBF of HBEC in vitro, imply a unique mechanism of action for mannitol on ciliary beating and might contribute to the improved clearance observed in mannitol-treated patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280546     DOI: 10.1089/jamp.2011.0914

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  9 in total

Review 1.  Mannitol dry powder for inhalation: in patients with cystic fibrosis.

Authors:  Celeste B Burness; Gillian M Keating
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

2.  Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.

Authors:  Hui Xin Ong; Daniela Traini; Giulia Ballerin; Lucy Morgan; Lachlan Buddle; Santo Scalia; Paul M Young
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

3.  Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

Authors:  W D Bennett; J Wu; F Fuller; J R Balcazar; K L Zeman; H Duckworth; K H Donn; T G O'Riordan; R C Boucher; S H Donaldson
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

4.  Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase.

Authors:  Zohreh Poursaleh; Ali Amini Harandi; Ensieh Vahedi; Mostafa Ghanei
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

5.  Perspective in future pharmacological approach to sulfur mustard lung injuries.

Authors:  Amin Saburi; Majid Shohrati; Mostafa Ghanei
Journal:  J Res Med Sci       Date:  2012-11       Impact factor: 1.852

Review 6.  Airway Epithelial Cell Cilia and Obstructive Lung Disease.

Authors:  Asma Yaghi; Myrna B Dolovich
Journal:  Cells       Date:  2016-11-11       Impact factor: 6.600

7.  Transcriptomic response of primary human airway epithelial cells to flavoring chemicals in electronic cigarettes.

Authors:  Hae-Ryung Park; Michael O'Sullivan; Jose Vallarino; Maya Shumyatcher; Blanca E Himes; Jin-Ah Park; David C Christiani; Joseph Allen; Quan Lu
Journal:  Sci Rep       Date:  2019-02-01       Impact factor: 4.379

8.  Rapid changes in mucociliary transport in the tracheal epithelium caused by unconditioned room air or nebulized hypertonic saline and mannitol are not determined by frequency of beating cilia.

Authors:  Susyn Joan Kelly; Paul Martinsen; Stanislav Tatkov
Journal:  Intensive Care Med Exp       Date:  2021-03-17

9.  Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.

Authors:  M Leigh Anne Daniels; Peadar G Noone
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.